Abstract

Introduction

Materials & Methods

Results

Discussion & Conclusion

References

Discussion
Board

1) Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T. and Rosenberg, S. A. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA, 91, 6458-6462 (1994).

2) Slingluff, C. L., Cox, A. L., Stover, J. M. J., Moore, M. M. Hunt, D. F. and Engelhard, A. H. Cytotoxic T-lymphocyte response to autologous human squamous cell cancer of the lung: epitope reconstitution with peptides extracted from HLA-Aw68. Cancer. Res., 54, 2731-2737 (1994).

3) Wolfel, T., Herr, W., Coulie, P., Schmitt, U., Buschenfelde, K. -H. M. and Knuth, A. Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones. Int. J. Cancer, 54, 636-644 (1993).

4) Goedegebuure, P. S., Douville, L. M., Li, H., Richmond, G. C., Schoof, D. D., Scavone, M. and Eberlein, T. J. Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study. J. Clin. Oncol., 13, 1939-1949 (1995) .

5) Robbins, P. F., El-Gamil, M., Kawakami, Y. and Rosenberg, S. A. Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res., 54, 3124-3126 (1994).

6) Crowley, N. J., Slingluff, C. L., Darrow, T. L. and Seigler, H. F. Generation of human autologous tumor-specific cytotoxic T cells using HLA-A2 matched allogeneic melanomas. Cancer Res., 50, 492-498 (1990).

7) Stevens, E. J., Jacknin, L., Robbins, P. F., Kawakami, Y., Gamil, M. E., Rosenberg, S. A. and Yannelli, J. R. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines-fine specificity and MART-1 melanoma antigen recognition. J. Immunol., 154, 762-771 (1995).

8) Bakker, A. B. H., Marland, G., De Boer, A. J., Huijbens, R. J. F., Danen, E. H. J., Adema, G. J. and Figdor, C. G. Generation of antimelanoma cytotoxic T lymphocytes from healthy donors after presentation of melanoma-associated antigen-derived epitopes by dendritic cells in vitro. Cancer Res., 55, 5330-5334 (1995).

9) Celis, E., Tsai, V., Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A. and Serra, H. M. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. Natl. Acad. Sci. USA, 91, 2105-2109 (1994).

10) Mukherji, B., Chakraborty, N. G., Yamasaki, S., Okino, T., Yamase, H., Sporn, J. R., Kurtzman, S. K., Ergin, M. T., Ozols, J., Meehan, J. and Mauri, F. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc. Natl. Acad. Sci. USA, 92, 8078-8082 (1995).

11) Wiedenfeld, E. A., Fernandez-Vina, M., Berzofsky, J. A. and Carbone, D. P. Evidence for selection against human lung cancers bearing p53 missense mutations which occur within the HLA-H0201 peptide consensus motif. Cancer Res., 54, 1175-1177 (1994).

12) van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., de Plaen, E., van den Eynde, B., Knuth, A. and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643-1647 (1991).

13) Disis, M. L., Calenoff, E., McLaughlin, G., Murphy, A. E., Chen, W., Groner, B., Jeschke, M., Lydon, N., McGlynn, E., Livingston, R. B., Moe, R. and Cheever, M. A. Existent T cell and antibody immunity to HER-2/neu protein in patients with breast cancer. Cancer Res., 54, 16-20 (1994).

14) Fujino, T., Rinsinger, J. I., Collins, N. K., Liu, F., Nishii, H., Takahashi, H., Westphal, E. M., Barrett, J. C., Sasaki, H., Kohler, M. F., Berchuck, A. and Boyd, J., Allelotype of endometrial carcinoma. Cancer Res., 54, 4294-4298 (1994).

15) Liu, B., Farrington, S. M., Petersen, G. M., Hamilton, S. R., Parsons, R., Papadopoulos, N., Fujiwara, T., Jen, J., Kinzler, K. W., Wyllie, A. H., Vogelstein, B. and Dunlop, M. G. Genetic instability occurs in the majority of young patients with colorectal cancer. Nat. Med., 1, 348-352 (1995).

16) Mitra, A. B., Murty, V. V. V. S., Li, R. G., Pratap, M., Luthra, U. K. and Chaganti, R. S. K. Allelotype analysis of cervical carcinoma. Cancer Res., 54, 4481-4487 (1994).

17) Schmidt-Wolf, G. D. and Schimidt-Wolf, I. G. H. Cytokines and gene therapy. Immunol. Today, 16, 173-175 (1995).

18) Bellone, M., Lezzi, G., Manfredi, A. A., Protti, M. P., Dellabona, P., Casorati, G. and Rugarli, C. In vitro priming of cytotoxic T lymphocytes against poorly immunogenic epitopes by engineered antigen-presenting cells. Eur. J. Immunol., 24, 2691-2698 (1994).

19) Guo, Y., Wu, M., Chen, H., Wang, X., Liu, G., Li, G., Ma, J. and Sy, M. S. Effective tumor vaccine generated by fusion of hepatoma cells with activated B cells. Science, 263, 518-520 (1994).

20) Hay, R. J., Park, J. G. and Gazdar, A. "Atlas of Human Tumot Cell Lines", (1994) Academic Press, Inc., San Diego.

21) Liu, S. Q., Shiba, R., Kim, B. S., Saijo, K. and Ohno, T. Long-term serum/plasma-free culture of human cytotoxic T lymphocytes induced from peripheral blood mononuclear cells, Cancer Immunol. Immunother., 39, 279-285 (1994).

22) Liu, S. Q., Saijo, K., Todoroki, K. and Ohno, T. Induction of human autologous cytotoxic T lymphocytes on formalin-fixed paraffin-embedded tumour sections. Nature Medicine, 1, 267-271 (1995) (Corrigendum: Allogeneic, not autologous, CTLs generated from formalin-fixed tumor section. Nat. Med., 2, 476-476 (1995) )

23) Liu, S. Q., Shiraiwa, H., Kawai, K., Hayashi, H., Akaza, H., Kim, B. S., Oki, A., Nishida, M., Kubo, T., Hashizaki, K., Saijo, K. and Ohno, T. Tumor-specific autologous cytotoxic T lymphocytes from tissue sections. Nat. Med., 2, 1283-1283 (1997).

24) Nakashima, M., Watanabe, T., Koprowski, H., Schuchter, L. and Steplewski, Z. In vitro expansion of tumor-specific, HLA-restricted human CD8+ cytolytic T lymphocytes. Cell. Immunol., 155, 53-61 (1994).

25) Kawai, K., Sasaki, T., Saijo-Kurita, K., Akaza, H., Koiso, K. and Ohno, T. Additive effects of antitumor drugs and lymphokine-activated killer cell cytotoxic activity in tumor cell killing determined by lactate-dehydrogenase-release assay. Cancer Immunol. Immunother., 35, 225-229 (1992).

26) Perussia, B., Ramoni, C., Anegon, I., Cuturi, M.C. and Faust, J. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines. Nat. Immunol. Cell Growth Regul., 6, 171-188 (1987).

27) Blasczyk, R., Hahn, U., Wehling, J., Huhn, D. and Salama, A. Complete subtyping of the HLA-A locus by sequence-specific amplification followed by direct sequencing or single-strand conformation polymorphism analysis. Tissue Antigens, 46, 86-95 (1995).

28) Raulet, D. H. and Held, W. Natural killer cell receptors: the offs and ons of NK cell recognition. Cell, 82, 697-700 (1995).

29) Topalian, S. L., Muul, L. M., Solomon, D., and Rosenberg, S. A. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials. J Immunol. Methods, 102, 127-141 (1987).

30) Okada, M., Kitahara, M., Kishimoto, S., Matsuda, T., Hirano, T. and Kishimoto, T. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J. Immunol., 141, 1543-1549 (1988).

31) Quentmeier, H., Klaucke, J., Muhlradt, P. F. and Drexler, H. G. Role of IL-6, IL-2, and IL-4 in the in vitro induction of cytotoxic T cells. J. Immunol., 149, 3316-3320 (1992).

Back to the top.